Qatar investors acquired stake in US cancer treatment firm for $40 million

Qatar investors of Qatar Investment Authority (QIA), and some other venture capital firms invested $40 million in OncoResponse, a healthcare company developing antibodies for the treatment of cancer.

Established in 2015 and based in Houston Texas, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies that will lead to the development of therapeutics for treatment of cancer. (QIA was established in 2005. Headquartered in Doha, it was founded as a means to strengthen the country's economy. the fund predominantly invests in international markets United States, Europe and Asia-Pacific and within Qatar outside the energy sector.) More details here.

Qatar Investment Authority is listed in the Middle East Investors Directory with the code BD44.